Systemic lupus erythematosus through the ages;Le lupus de l'enfant à travers les âges

Revue du Rhumatisme Monographies

Volumn 79, Issue 1, 2012, Pages 24-29

  Belot, Alexandre ^a   Cimaz, Rolando ^b  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Children; Complement deficiency; Growth; Monogenic lupus; Neonatal lupus; Puberty; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; IMMUNOSUPPRESSIVE AGENT; RO ANTIBODY;

ATRIOVENTRICULAR BLOCK; CHILD CARE; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY DIAGNOSIS; EARLY INTERVENTION; HEART DISEASE; HEMATOLOGIC DISEASE; HUMAN; INFLAMMATION; LIVER DISEASE; MULTIPLE ORGAN FAILURE; NEWBORN DISEASE; NEWBORN LUPUS; PEDIATRIC LUPUS; PEDIATRICS; PROGNOSIS; RISK REDUCTION; SHORT SURVEY; SKIN DISEASE; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84856509083     PISSN: 18786227     EISSN: 22120920     Source Type: Journal    
DOI: 10.1016/j.monrhu.2011.11.001     Document Type: Short Survey

References (37)

1. Petty R.E.L.R. Systemic lupus erytematosus. Textbook of pediatric rheumatology 2005, Elsevier Saunders, Philadelphia. J.T.P.R. Cassidy, R.M. Laxer, C.B. Lindsey (Eds.).
2. Brunner H.I., Gladman D.D., Ibanez D., et al. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008, 58:556-562.
3. Pluchinotta F.R., Schiavo B., Vittadello F., et al. Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes. Lupus 2007, 16:550-555.
4. Kreindler J., Ellis D., Vats A., et al. Infantile systemic lupus erythematosus presenting with pulmonary hemorrhage. Pediatr Nephrol 2005, 20:522-525.
5. Lehman T.J., McCurdy D.K., Bernstein B.H., et al. Systemic lupus erythematosus in the first decade of life. Pediatrics 1989, 83:235-239.
6. Bader-Meunier B., Armengaud J.B., Haddad E., et al. Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 2005, 146:648-653.
7. Cameron J.S. Lupus nephritis in childhood and adolescence. Pediatr Nephrol 1994, 8:230-249.
8. Weening J.J., D'Agati V.D., Schwartz M.M., et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004, 15:241-250.
9. Hagelberg S., Lee Y., Bargman J., et al. Longterm followup of childhood lupus nephritis. J Rheumatol 2002, 29:2635-2642.
10. Yang L.Y., Chen W.P., Lin C.Y. Lupus nephritis in children--a review of 167 patients. Pediatrics 1994, 94:335-340.
11. Sibbitt W.L., Brandt J.R., Johnson C.R., et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002, 29:1536-1542.
12. Olfat M.O., Al-Mayouf S.M., Muzaffer M.A. Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus. Clin Rheumatol 2004, 23:395-399.
13. Brunner H.I., Jones O.Y., Lovell D.J., et al. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage. Lupus 2003, 12:600-606.
14. Harel L., Sandborg C., Lee T., et al. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol 2006, 33:1873-1877.
15. Benseler S.M., Silverman E.D. Neuropsychiatric involvement in pediatric systemic lupus erythematosus. Lupus 2007, 16:564-571.
16. Harel L., Mukamel M., Brik R., et al. Peripheral neuropathy in pediatric systemic lupus erythematosus. Pediatr Neurol 2002, 27:53-56.
17. Brunner H.I., Ruth N.M., German A., et al. Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus. Arthritis Rheum 2007, 57:1174-1182.
18. Sandborg C., Ardoin S.P., Schanberg L. Therapy insight: cardiovascular disease in pediatric systemic lupus erythematosus. Nat Clin Pract Rheumatol 2008, 4:258-265.
19. Ciftci E., Yalcinkaya F., Ince E., et al. Pulmonary involvement in childhood-onset systemic lupus erythematosus: a report of five cases. Rheumatology (Oxford) 2004, 43:587-591.
20. Klein A., Cimaz R., Quartier P., et al. Causes of death in pediatric systemic lupus erythematosus. Clin Exp Rheumatol 2009, 27:538-539.
21. Frank M.M., Hamburger M.I., Lawley T.J., et al. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 1979, 300:518-523.
22. Liote F., Angle J., Gilmore N., et al. Asplenism and systemic lupus erythematosus. Clin Rheumatol 1995, 14:220-223.
23. Cimaz R., Descloux E. Pediatric antiphospholipid syndrome. Rheum Dis Clin North Am 2006, 32:553-573.
24. Compeyrot-Lacassagne S., Tyrrell P.N., Atenafu E., et al. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. Arthritis Rheum 2007, 56:1966-1973.
25. Campos L.M., Kiss M.H., D'Amico E.A., et al. Antiphospholipid antibodies in 57 children and adolescents with systemic lupus erythematosus. Rev Hosp Clin Fac Med Sao Paulo 2003, 58:157-162.
26. Bandeira M., Buratti S., Bartoli M., et al. Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus. Lupus 2006, 15:515-520.
27. Silva C.A., Hallak J., Pasqualotto F.F., et al. Gonadal function in male adolescents and young males with juvenile onset systemic lupus erythematosus. J Rheumatol 2002, 29:2000-2005.
28. Brunner H.I., Silverman E.D., To T., et al. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002, 46:436-444.
29. Cimaz R., Duquesne A. Syndromes lupus néonatal. Arch Pediatr 2006, 13:473-478.
30. Buyon J.P., Hiebert R., Copel J., et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998, 31:1658-1666.
31. Cimaz R., Meroni P.L., Brucato A., et al. Concomitant disappearance of electrocardiographic abnormalities and of acquired maternal autoantibodies during the first year of life in infants who had QT interval prolongation and anti-SSA/Ro positivity without congenital heart block at birth. Arthritis Rheum 2003, 48:266-268.
32. Saleeb S., Copel J., Friedman D., et al. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999, 42:2335-2345.
33. Guettrot-Imbert G., Cohen L., Fermont L., et al. A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal Anti-SSA/Ro and Anti-SSB/La antibodies. J Rheumatol 2011, 38:378-386.
34. Groves A.M., Allan L.D., Rosenthal E. Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. Circulation 1995, 92:3394-3396.
35. Manderson A.P., Botto M., Walport M.J. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004, 22:431-456.
36. Wu J., Wilson J., He J., et al. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 1996, 98:1107-1113.
37. Kone-Paut I., Piram M., Guillaume S., Tran T.A. Lupus in adolescence. Lupus 2007, 16:606-612.